Hinge Bio
Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.
Company Operating Status
Active
Country
Crunchbase URL
Email Address
info@hingebio.com
Founder
Latest Funding Round Date
January 15, 2025
Latest Funding Round Amount (USD)
30,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
11 – 50
Pitchbook URL
Total Funding Amount (USD)
30,000,000
Official Website
Find more companies like Hinge Bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.